Jeffrey JK
UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America.
ArticlePsilocybin
Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trial.
ArticlePsilocybin
Divergent Effects of Psilocybin for 2 Patients Participating in a Psilocybin-assisted Cognitive Behavioral Therapy Trial for Major Depressive Disorder.
ArticlePsilocybin
Clinical Research Trials of Psychedelic-Assisted Therapy in Adolescents Aged 16 to 17 Years: Rationale Balanced With Caution.
ArticlePsilocybin